We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
128 hedge funds and large institutions have $365M invested in Puma Biotechnology in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 36
18% more capital invested
Capital invested by funds: $309M → $365M (+$56.5M)
2% more funds holding
Funds holding: 126 → 128 (+2)
8% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 25
4.06% less ownership
Funds ownership: 93.21% → 89.15% (-4.1%)
35% less call options, than puts
Call options by funds: $2.22M | Put options by funds: $3.42M
Holders
128
Holders Change
+2
Holders Change %
+1.59%
% of All Funds
2.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
27
Increased
45
Reduced
36
Closed
25
Calls
$2.22M
Puts
$3.42M
Net Calls
-$1.2M
Net Calls Change
-$843K
Top Buyers
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$21.4M |
| 2 |
DM
Deerfield Management
New York
|
-$8.13M |
| 3 |
Millennium Management
New York
|
-$8.03M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.62M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.2M |
